News
3M Completes Divestment of Drug Delivery Division
May 5, 20203M has finalized the sale of the majority of its drug delivery business to Altaris Capital Partners LLC.
The US$650 million divestment was announced late last year. Per the terms of the sale, more than 900 employees of the division, which produces inhalers, micro-needles, and other technologies, will transfer to Altaris, which will operate the segment as a new company known as Kindeva Drug Delivery.
About 3M
With global sales of US$33 billion, 3M is a leading producer of thousands of products ranging from chemicals, filtration systems, and safety and protection equipment to office, graphics, and health care equipment. For more information, visit www.3m.com.